A

Anteris Technologies Global Corp. (AVR)

NGM – Real vaqt narxi. Valyuta: USD

8.80

-0.37 (-4.03%)

Bozor ochiq: Aug 12, 2026, 12:53 PM EDT

9.18

+0.01 (0.11%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

A

Anteris Technologies Global Corp. (AVR)

NGM – Real vaqt narxi. Valyuta: USD

8.80

-0.37 (-4.03%)

Bozor ochiq: Aug 12, 2026, 12:53 PM EDT

9.18

+0.01 (0.11%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

11.08.2026

Anteris Technologies Announces Results for the Second Quarter of 2026

MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2026, and provided a corporate update. Q2 2026 Highlights Secured U.S. Medicare reimbursement eligibility for the global pivotal PARADIGM Trial under a Centers for Medicare & Medicaid Services (CMS) national coverage policy, enabling reimbursement for eligible procedures at U.S. sites.

Videolar

No Data

There is no data to display

Press-relizlar

11.08.2026

Anteris Technologies Announces Results for the Second Quarter of 2026

MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2026, and provided a corporate update. Q2 2026 Highlights Secured U.S. Medicare reimbursement eligibility for the global pivotal PARADIGM Trial under a Centers for Medicare & Medicaid Services (CMS) national coverage policy, enabling reimbursement for eligible procedures at U.S. sites.

Search stocks

Anteris Technologies Global Corp. (AVR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Anteris Technologies Global Corp. (AVR)

Anteris Technologies Announces Results for the Second Quarter of 2026

Videolar

No Data

Press-relizlar

Anteris Technologies Announces Results for the Second Quarter of 2026